康躍科技(300391.SZ):重大資產重組相關財務資料有效期延長
格隆匯 9 月 29日丨康躍科技(300391.SZ)公佈,公司擬通過支付現金方式收購湖北長江大藥房連鎖有限公司(“長江連鎖”)、浙江財通資本投資有限公司(“財通資本”)、王冬香持有的湖北長江星醫藥股份有限公司(“長江星”、“標的公司”)52.7535%的股權,此次交易合計對價為14.14億元,此次交易構成重大資產重組。
標的公司財務資料基準日為2020年3月31日。根據《公開發行證券的公司信息披露內容與格式準則第26號——上市公司重大資產重組》第六十三條規定:“經審計的最近一期財務資料在財務報告截止日後六個月內有效,特別情況下可申請適當延長,但延長時間至多不超過一個月。”此次交易標的公司經審計的最近一期財務資料有效期截止日為2020年9月30日。
相關盡職調查和審計工作的推進過程,恰逢新型冠狀病毒肺炎疫情影響期間,標的公司的主要生產經營場所位於湖北省,復產復工較晚,同時,標的公司部分客户和供應商亦存在不同程度的延期復工,上述情況導致中介機構審計、盡職調查相關工作的時間相應受到影響。
因此,特申請此次交易的審計報告財務資料有效期延長1個月,即有效期截止日由2020年9月30日延長至2020年10月31日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.